Clinical Benefits of Baricitinib Therapy According to Scalp Hair Regrowth in Patients with Severe Alopecia Areata
Abstract Objectives The present analyses report integrated results from BRAVE-AA1 (NCT03570749) and BRAVE-AA2 (NCT03899259) on the clinical benefits of baricitinib treatment on the basis of the amount of scalp hair regrowth through 52 weeks of treatment. Methods This post hoc analysis was conducted...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Adis, Springer Healthcare
2023-11-01
|
| シリーズ: | Dermatology and Therapy |
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1007/s13555-023-01063-2 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|